Diamyd Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Millions SEK. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Cap	158	1,554	1,637	840	1,095	2,355
Market Cap Growth	-89.83%	-5.11%	94.98%	-23.31%	-53.50%	-11.83%
Enterprise Value	-188.02	1,277	1,505	712.28	935.4	2,215
Last Close Price	1.02	11.30	16.42	9.79	14.24	32.90
PE Ratio	-	-	-	-	-	36.56
Forward PE	-	129.14	260.00	260.00	260.00	260.00
PS Ratio	365.94	309.82	375.22	224.13	423.62	5303.73
PB Ratio	0.61	5.55	11.22	4.96	5.11	12.44
P/TBV Ratio	0.55	4.54	10.66	4.52	5.08	12.14
EV/Sales Ratio	-	254.55	344.89	190.09	361.86	4989.82
Net Debt / Equity Ratio	-1.33	-0.99	-0.91	-0.75	-0.74	-0.74
Net Debt / EBITDA Ratio	1.23	1.57	0.98	1.10	1.40	1.64
Net Debt / FCF Ratio	1.78	1.54	0.97	1.04	1.25	1.23
Asset Turnover	0.01	0.02	0.02	0.02	0.01	0.00
Quick Ratio	15.41	10.23	3.38	6.63	7.59	12.37
Current Ratio	15.50	10.64	3.98	7.09	8.10	14.29
Return on Equity (ROE)	-38.17%	-79.72%	-96.32%	-60.49%	-51.29%	45.88%
Return on Assets (ROA)	-81.11%	-64.33%	-69.32%	-54.62%	-53.97%	-58.98%
Return on Invested Capital (ROIC)	-	-2238.95%	-528.95%	-250.18%	-225.97%	-318.02%
Return on Capital Employed (ROCE)	-87.06%	-72.98%	-80.76%	-60.24%	-58.33%	-65.23%
Earnings Yield	-	-	-	-	-	2.74%
Buyback Yield / Dilution	-36.72%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%
Total Shareholder Return	-36.72%	-18.81%	-20.98%	-2.29%	-9.65%	-0.90%